Top
image credit: Adobe Stock

Modular plug-and-produce facilities for cell therapies

November 7, 2022

At the start of 2021, a crane lifted a shrink-wrapped, elongated structure off a truck flatbed and through a window into an upper floor of Shanghai’s ATLATL Innovation Center. Two months later, that structure was a full-fledged facility for the clinical production of cell therapy products. The idea behind the project was simple: to create a lightweight GMP cell manufacturing unit that is fast to assemble, easy to deliver, and that can be used to scale out production in compliance with regulatory requirements. The outcome was an engineering feat: a plug-and-produce module with connections for clean utilities that houses cell manufacturing in automated, fully enclosed, and sterile systems. A ready-to-go “cell factory”.

Read More on Biopharma Dive